Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 309

1.

Serum Lactate and A Relative Change in Lactate as Predictors of Mortality in Patients with Cardiogenic Shock - Results from The Cardshock Study.

Lindholm MG, Hongisto M, Lassus J, Spinar J, Parissis J, Banaszewski M, Silva-Cardoso J, Carubelli V, Salvatore D, Sionis A, Mebazaa A, Veli-Pekka H, Kober L.

Shock. 2019 Apr 5. doi: 10.1097/SHK.0000000000001353. [Epub ahead of print]

PMID:
30973460
2.

Prognostic value of NT-proBNP added to clinical parameters to predict two-year prognosis of chronic heart failure patients with mid-range and reduced ejection fraction - A report from FAR NHL prospective registry.

Spinar J, Spinarova L, Malek F, Ludka O, Krejci J, Ostadal P, Vondrakova D, Labr K, Spinarova M, Pavkova Goldbergova M, Benesova K, Jarkovsky J, Parenica J.

PLoS One. 2019 Mar 26;14(3):e0214363. doi: 10.1371/journal.pone.0214363. eCollection 2019.

3.

Prescription and dosage of RAAS inhibitors in patients with chronic heart failure in the FAR NHL registry.

Špinarová M, Špinar J, Pařenica J, Špinarová L, Málek F, Lábr K, Ludka O, Jarkovský J.

Vnitr Lek. Winter 2019;65(1):13-14.

PMID:
30823832
4.

Current Use and Impact on 30-Day Mortality of Pulmonary Artery Catheter in Cardiogenic Shock Patients: Results From the CardShock Study.

Sionis A, Rivas-Lasarte M, Mebazaa A, Tarvasmäki T, Sans-Roselló J, Tolppanen H, Varpula M, Jurkko R, Banaszewski M, Silva-Cardoso J, Carubelli V, Lindholm MG, Parissis J, Spinar J, Lassus J, Harjola VP, Masip J.

J Intensive Care Med. 2019 Feb 7:885066619828959. doi: 10.1177/0885066619828959. [Epub ahead of print]

PMID:
30732522
5.

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

Sawhney JP, Kothiwale VA, Bisne V, Durgaprasad R, Jadhav P, Chopda M, Vanajakshamma V, Meena R, Vijayaraghavan G, Chawla K, Allu J, Pieper KS, John Camm A, Kakkar AK; GARFIELD-AF Investigators.

Indian Heart J. 2018 Nov - Dec;70(6):828-835. doi: 10.1016/j.ihj.2018.09.001. Epub 2018 Sep 12.

6.

Renal Functions and Prognosis Stratification in Chronic Heart Failure Patients and the Importance of Neutrophil Gelatinase-Associated Lipocalin.

Lábr K, Špinar J, Pařenica J, Špinarová L, Málek F, Špinarová M, Ludka O, Jarkovský J, Benešová K, Goldbergová-Pávková M, Lábrová R.

Kidney Blood Press Res. 2018;43(6):1865-1877. doi: 10.1159/000495819. Epub 2018 Dec 7.

7.

Arrhythmias and conductance disturbances and heart failure.

Vítovec J, Špinar J, Špinarová L.

Vnitr Lek. Fall 2018;64(9):874-877.

PMID:
30442001
8.

Comorbidities in heart failure.

Vítovec J, Špinarová L, Špinar J.

Vnitr Lek. Fall 2018;64(9):867-873.

PMID:
30442000
9.

The heart transplantation.

Špinarová L, Špinar J, Vítovec J.

Vnitr Lek. Fall 2018;64(9):860-866.

PMID:
30441999
10.

Pathophysiology, causes and epidemiology of chronic heart failure.

Špinar J, Špinarová L, Vítovec J.

Vnitr Lek. Fall 2018;64(9):834-838.

PMID:
30441995
11.

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.

Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Silverman MG, Zelniker TA, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Ruff CT, Gause-Nilsson IAM, Fredriksson M, Johansson PA, Langkilde AM, Sabatine MS; DECLARE–TIMI 58 Investigators.

N Engl J Med. 2019 Jan 24;380(4):347-357. doi: 10.1056/NEJMoa1812389. Epub 2018 Nov 10.

PMID:
30415602
12.

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.

Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators.

N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7.

PMID:
30403574
13.

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial.

Bohula EA, Scirica BM, Inzucchi SE, McGuire DK, Keech AC, Smith SR, Kanevsky E, Murphy SA, Leiter LA, Dwyer JP, Corbalan R, Hamm C, Kaplan L, Nicolau JC, Ophuis TO, Ray KK, Ruda M, Spinar J, Patel T, Miao W, Perdomo C, Francis B, Dhadda S, Bonaca MP, Ruff CT, Sabatine MS, Wiviott SD; CAMELLIA-TIMI 61 Steering Committee Investigators.

Lancet. 2018 Nov 24;392(10161):2269-2279. doi: 10.1016/S0140-6736(18)32328-6. Epub 2018 Oct 4.

PMID:
30293771
14.

Correction to: Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients.

Léopold V, Gayat E, Pirracchio R, Spinar J, Parenica J, Tarvasmäki T, Lassus J, Harjola VP, Champion S, Zannad F, Valente S, Urban P, Chua HR, Bellomo R, Popovic B, Ouweneel DM, Henriques JPS, Simonis G, Lévy B, Kimmoun A, Gaudard P, Basir MB, Markota A, Adler C, Reuter H, Mebazaa A, Chouihed T.

Intensive Care Med. 2018 Nov;44(11):2022-2023. doi: 10.1007/s00134-018-5372-9.

PMID:
30215188
15.

Rationale and design of randomized controlled trial protocol of cardiovascular rehabilitation based on the use of telemedicine technology in the Czech Republic (CR-GPS).

Batalik L, Dosbaba F, Hartman M, Batalikova K, Spinar J.

Medicine (Baltimore). 2018 Sep;97(37):e12385. doi: 10.1097/MD.0000000000012385.

16.

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.

Spyropoulos AC, Ageno W, Albers GW, Elliott CG, Halperin JL, Hiatt WR, Maynard GA, Steg PG, Weitz JI, Suh E, Spiro TE, Barnathan ES, Raskob GE; MARINER Investigators.

N Engl J Med. 2018 Sep 20;379(12):1118-1127. doi: 10.1056/NEJMoa1805090. Epub 2018 Aug 26.

17.

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.

Bohula EA, Wiviott SD, McGuire DK, Inzucchi SE, Kuder J, Im K, Fanola CL, Qamar A, Brown C, Budaj A, Garcia-Castillo A, Gupta M, Leiter LA, Weissman NJ, White HD, Patel T, Francis B, Miao W, Perdomo C, Dhadda S, Bonaca MP, Ruff CT, Keech AC, Smith SR, Sabatine MS, Scirica BM; CAMELLIA–TIMI 61 Steering Committee and Investigators.

N Engl J Med. 2018 Sep 20;379(12):1107-1117. doi: 10.1056/NEJMoa1808721. Epub 2018 Aug 26.

18.

Comparison of two modes of long-term ECG monitoring to assess the efficacy of catheter ablation for paroxysmal atrial fibrillation.

Chovancik J, Bulkova V, Wichterle D, Toman O, Rybka L, Januska J, Spinar J, Fiala M.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019 Feb;163(1):54-60. doi: 10.5507/bp.2018.031. Epub 2018 Jun 21.

19.

MicroRNAs in pathophysiology of acute myocardial infarction and cardiogenic shock.

Goldbergova MP, Lipkova J, Fedorko J, Sevcikova J, Parenica J, Spinar J, Masarik M, Vasku A.

Bratisl Lek Listy. 2018;119(6):341-347. doi: 10.4149/BLL_2018_064.

PMID:
29947233
20.

Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients.

Léopold V, Gayat E, Pirracchio R, Spinar J, Parenica J, Tarvasmäki T, Lassus J, Harjola VP, Champion S, Zannad F, Valente S, Urban P, Chua HR, Bellomo R, Popovic B, Ouweneel DM, Henriques JPS, Simonis G, Lévy B, Kimmoun A, Gaudard P, Basir MB, Markota A, Adler C, Reuter H, Mebazaa A, Chouihed T.

Intensive Care Med. 2018 Jun;44(6):847-856. doi: 10.1007/s00134-018-5222-9. Epub 2018 Jun 1. Erratum in: Intensive Care Med. 2018 Nov;44(11):2022-2023.

PMID:
29858926

Supplemental Content

Loading ...
Support Center